Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
Thrombosis & Haemostasis Journal (TH Open) has recently shared a promising data on Emicizumab efficacy on X:
”Implementing an Assay to detect Anti-drug Antibody against Emicizumab: Experience from One Center in France. Auditeau et al. evaluated the effectiveness of a modified bridging ELISA in detecting anti-drug antibodies.”
Read the full article here.
A bispecific antibody mimicking factor VIII, is approved for prophylaxis in hemophilia A — but what could possibly go wrong with a drug designed to work perfectly?
Although rare, anti-drug antibodies (ADA) can reduce its efficacy,using data from One center in France.
The study by Claire Auditeau et al. aimed to investigate potential causes behind the loss of Emicizumab efficacy.
Using a modified bridging ELISA, ADA was detected in two patients—one newly identified with a neutralizing ADA that blocked Emicizumab’s binding to factors IX and X.
In ADA-negative cases, bispecific antibody’s levels improved following adherence adjustments.
The findings suggest that the assay may help distinguish ADA-related loss of efficacy from non-immunologic causes in patients with unexplained bleeding.
Updates on thrombosis and hemostasis field advancements featured in Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants